Global University Venturing

GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, an MIT spinout that has now raised at least $166m to date.

OSI has returned to back Oxford indoor mapping spinout Navenio as the latter expands the market for its hospital workforce allocation system.

John Öhd is to become Karolinska Institute's chief scientific officer on the back of 13 years of biotech industry expertise.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Hiroyuki Ueno's work at Kyoto University's venture fund has been rewarded with a promotion to senior officer and executive manager.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

AVIC invested in the CAS-backed industrial internet-of-things satellite operator Commsat's latest round to bring its overall funding to $68.2m.

Immune cell mapping technology developer Immunai has emerged from stealth to commercialise inventions from Stanford and PICI labs.

Haier Financial Holdings has backed a $254m funding round for CloudWalk, a spinout of Chinese Academy of Sciences.

University of Tokyo and Keio University joined multiple corporates in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

The Harvard motor neurone disease drug developer secured the return of Amgen Ventures for its series A round.